Addus Homecare (NASDAQ:ADUS) and Wound Management Technologies (OTCMKTS:WNDM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk.

Risk and Volatility

Addus Homecare has a beta of -0.2, suggesting that its stock price is 120% less volatile than the S&P 500. Comparatively, Wound Management Technologies has a beta of 2.02, suggesting that its stock price is 102% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Addus Homecare and Wound Management Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus Homecare 0 0 7 0 3.00
Wound Management Technologies 0 0 0 0 N/A

Addus Homecare presently has a consensus price target of $76.86, suggesting a potential upside of 17.11%. Given Addus Homecare’s higher possible upside, equities research analysts clearly believe Addus Homecare is more favorable than Wound Management Technologies.

Valuation & Earnings

This table compares Addus Homecare and Wound Management Technologies’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Addus Homecare $518.12 million 1.66 $17.50 million $1.69 38.83
Wound Management Technologies $6.30 million 2.16 $330,000.00 N/A N/A

Addus Homecare has higher revenue and earnings than Wound Management Technologies.

Institutional & Insider Ownership

95.2% of Addus Homecare shares are owned by institutional investors. 34.8% of Addus Homecare shares are owned by insiders. Comparatively, 9.6% of Wound Management Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.


This table compares Addus Homecare and Wound Management Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Addus Homecare 3.38% 9.22% 5.99%
Wound Management Technologies 1.79% 12.58% 5.17%


Addus Homecare beats Wound Management Technologies on 8 of the 11 factors compared between the two stocks.

Addus Homecare Company Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2017, the company served consumers through 116 offices located in 24 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Wound Management Technologies Company Profile

WNDM Medical Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. The company offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as Wound Management Technologies, Inc. and changed its name to WNDM Medical Inc. in April 2017. WNDM Medical Inc. was founded in 1982 and is based in Fort Worth, Texas.

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with's FREE daily email newsletter.